Newsroom

You are here

For the media

Contact David Martinson at 612-624-7403 or dpmartin@umn.edu for media interviews with any expert within the University's health sciences programs. If you are not a member of the media and have questions about your health or other academic matters, please contact the expert directly.

Media seeking experts outside the health sciences can reach the University's news service at 612-624-5551.

Major Donation Will Improve, Sustain Sexual Health Research and Care

Monday, March 6, 2017

The University of Minnesota Medical School today announced a significant donation that will provide sustained support for its Program in Human Sexuality while providing an incentive for additional individual donations. This area of health care is facing a shortage of funding for research and care programs across the country.

UMN researchers find reducing radiation therapy exposure leads to lower rate of secondary cancer in survivors

Tuesday, February 28, 2017

Survivors of childhood cancers have fewer secondary cancers, according to new research from the Masonic Cancer Center, University of Minnesota and St. Jude Children’s Research Hospital. Compared with those diagnosed in the 1970s, patients diagnosed after 1990 are experiencing better outcomes. Researchers believe the difference comes from a reduction in exposure to therapeutic radiation.

The results are published today in the Journal of the American Medical Association. Work was led by the Masonic Cancer Center, University of Minnesota in partnership with investigators at St. Jude Children’s Research Hospital. It utilized data from the Childhood Cancer Survivor Study (CCSS).

Cancer drug developed by Masonic Cancer Center, University of Minnesota researchers increases survival in dogs; shows potential for use in humans

Monday, February 13, 2017

A breakthrough trial at the Masonic Cancer Center, University of Minnesota testing a new UMN-developed drug resulted in improved survival rates for dogs diagnosed with a cancer called hemangiosarcoma (HSA). The results were recently published in the journal Molecular Cancer Therapeutics.